GUTLINK4KIDS Intervention (GUTLINK4KIDS)

April 27, 2026 updated by: Piril Hepsomali, University of Reading

The Impact of Chronic Consumption of Prebiotics on Cognitive and Affective Outcomes, Gut Microbiome Diversity and Composition in 3-5 Year Olds: a Double-blind Placebo-controlled, Parallel-groups Randomised Controlled Trial

This study aims to investigate the chronic effects of prebiotic consumption on cognitive, behavioural and gut microbiome outcomes in children aged 3-5 years.

Study Overview

Detailed Description

This study will employ a double-blind, randomised, placebo-controlled parallel design to investigate the chronic effects of 8-week-long prebiotic consumption on cognitive, behavioural, and gut microbiome, outcomes in 3-5-year-old children with insufficient fibre intake (less than the average 10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds). One hundred and six participants will be randomised to Intervention or Placebo groups where they will be consuming 5g of prebiotic fibre or 5g of placebo (matched placebo powder) per day for 8-weeks. Outcome measures will be acquired before and after a 8-week chronic supplementation. These will include cognitive and behavioural outcomes of the parents and children. In addition, stool samples will be collected at the baseline and at week 8 to assess microbiome diversity and composition. Additionally, after 4-weeks of wash-out, at 12 weeks, parents will be asked to completed online questionnaires assessing cognitive and behavioural outcome of their children.

Study Type

Interventional

Enrollment (Estimated)

106

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Berkshire
      • Reading, Berkshire, United Kingdom, RG6 6BZ
        • Recruiting
        • University of Reading, School of Psychology and Clinical Languages
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Parents (18 years and over) of generally healthy children aged 3-5-years-old (36-71 months) with lower dietary fibre intake than the recommended daily amount (10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds).

Exclusion Criteria:

  • Children with a significant acute or chronic co-existing illness (including inflammatory bowel disease, functional gastrointestinal disorders, coeliac disease etc, neurodevelopmental, immunological, psychiatric, or metabolic disorders.
  • Children who have taken any pre/probiotic supplements or antibiotic treatment within the 4 weeks prior to enrolment.
  • Children with food allergies and intolerances

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prebiotic (powder)
Children will consume two (one in the morning and one in the evening) 2.5g of prebiotic sachets a day (mixed with food and drink).
5g of prebiotic fibre
Placebo Comparator: Matched placebo (powder)
Children will consume two (one in the morning and one in the evening) 2.5g of placebo sachets a day (mixed with food and drink).
5g of placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child Behaviour Checklist Ages 1.5-5
Time Frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
Parents will be asked to complete this validated measure that includes 100 items that assesses a child's emotional, behavioral, and social problems.
This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emotion Regulation Skills Questionnaire
Time Frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
Parents will be asked to complete this measure that includes 52 items that assesses a child's adaptive and maladaptive emotion regulation skills.
This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
Childhood Autism Spectrum Test
Time Frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
Parents will be asked to complete this measure that includes 44 items that assesses a child's developmental differences in social and communication functioning
This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
Bristol Stool Chart
Time Frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
Parents will be asked to complete this measure that includes 1 item that assesses a child's stool consistency.
This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
Gut microbiome diversity
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Children's stool samples will be collected to measure gut microbiome diversity. Indices of alpha and beta diversity will be analysed (16s sequencing).
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Gut microbiome composition
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Children's stool samples will be collected to measure gut microbiome composition (genus and species) (16s sequencing).
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attentional Control Scale
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Parents will be asked to complete this measure that includes 20 items that assesses their own attentional control.
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Difficulties in Emotional Regulation Scale
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Parents will be asked to complete this measure that includes 36 items that assesses their own emotion regulation skills.
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Patient Health Questionnaire-8
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Parents will be asked to complete this measure that includes 8 items that assesses their own depressed mood.
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Generalised Anxiety Disorder-7
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Parents will be asked to complete this measure that includes 7 items that assesses their own anxious mood.
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Child-Parent Relationship Scale
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Parents will be asked to complete this measure that includes 30 items that assesses their relationship with their child/children.
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
Scottish Collaborative Group Child VC2 Food Frequency Questionnaire
Time Frame: This measure will be taken at baseline (pre intervention).
Parents will be asked to complete this measure that assesses their child's habitual food intake.
This measure will be taken at baseline (pre intervention).
Child Eating Behaviour Questionnaire
Time Frame: This measure will be taken at baseline (pre intervention).
Parents will be asked to complete this measure that assesses their child's eating behaviour.
This measure will be taken at baseline (pre intervention).
Dietary recall
Time Frame: This measure will be taken during screening and at week 8 (post intervention).
This measure will be used to screen participants. Parents will be asked to complete this measure that assesses their child's food intake. Children with insufficient fibre intake (less than the average 10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds) will be eligible for the study.
This measure will be taken during screening and at week 8 (post intervention).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2027

Study Registration Dates

First Submitted

February 3, 2026

First Submitted That Met QC Criteria

February 3, 2026

First Posted (Actual)

February 10, 2026

Study Record Updates

Last Update Posted (Actual)

April 28, 2026

Last Update Submitted That Met QC Criteria

April 27, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep

Clinical Trials on Prebiotic powder

Subscribe